BUZZ-Australia's Osteopore jumps on partnership to develop bone implant

Reuters09-09

BUZZ-Australia's <a href="https://laohu8.com/S/OSX.AU">Osteopore</a> jumps on partnership to develop bone implant

** Shares of Osteopore OSX.AX rise as much as 30.4% to A$0.015, their highest level since July 29; last up 13%

** Regenerative medicine co announces collaboration with Tan Tock Seng Hospital for the development of a novel implant for avascular necrosis (AVN)

** AVN is a condition where bone tissue dies due to poor blood supply

** About 23.7 mln shares traded, 6.8x the 30-day average

** YTD stock down 62.9%, including current session's move

(Reporting by Ananya Verma in Bengaluru)

((ananya.verma@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2566656732?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-09 08:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2566656732","market":"fut","top_or_hot":-1,"title":"BUZZ-Australia's Osteopore jumps on partnership to develop bone implant","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's <a href=\"https://laohu8.com/S/OSX.AU\">Osteopore</a> jumps on partnership to develop bone implant</title></head><body><p>** Shares of Osteopore <span>OSX.AX</span> rise as much as 30.4% to A$0.015, their highest level since July 29; last up 13%</p><p>** Regenerative medicine co <span>announces</span> collaboration with Tan Tock Seng Hospital for the development of a novel implant for avascular necrosis (AVN)</p><p>** AVN is a condition where bone tissue dies due to poor blood supply</p><p>** About 23.7 mln shares traded, 6.8x the 30-day average</p><p>** YTD stock down 62.9%, including current session's move  </p><p>(Reporting by Ananya Verma in Bengaluru)</p><p>((ananya.verma@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Australia's Osteopore jumps on partnership to develop bone implant</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Australia's Osteopore jumps on partnership to develop bone implant\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-09 08:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-Australia's <a href=\"https://laohu8.com/S/OSX.AU\">Osteopore</a> jumps on partnership to develop bone implant</title></head><body><p>** Shares of Osteopore <span>OSX.AX</span> rise as much as 30.4% to A$0.015, their highest level since July 29; last up 13%</p><p>** Regenerative medicine co <span>announces</span> collaboration with Tan Tock Seng Hospital for the development of a novel implant for avascular necrosis (AVN)</p><p>** AVN is a condition where bone tissue dies due to poor blood supply</p><p>** About 23.7 mln shares traded, 6.8x the 30-day average</p><p>** YTD stock down 62.9%, including current session's move  </p><p>(Reporting by Ananya Verma in Bengaluru)</p><p>((ananya.verma@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7126","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250909:nL3N3UW00Z:1","article_id":"2566656732","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2566656732","pubTimestamp":1757378654,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Australia's Osteopore jumps on partnership to develop bone implant** Shares of Osteopore OSX.AX rise as much as 30.4% to A$0.015, their highest level since July 29; last up 13%** Regenerative medicine co announces collaboration with Tan Tock Seng Hospital for the development of a novel implant for avascular necrosis ** AVN is a condition where bone tissue dies due to poor blood supply** About 23.7 mln shares traded, 6.8x the 30-day average** YTD stock down 62.9%, including current session's move  ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7126":"医疗保健用品","OSX.AU":"Osteopore"},"translate_title":"BUZZ-澳大利亚骨质疏松症公司合作开发骨植入物","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OSX.AU":0.9},"content_text":"BUZZ-Australia's Osteopore jumps on partnership to develop bone implant** Shares of Osteopore OSX.AX rise as much as 30.4% to A$0.015, their highest level since July 29; last up 13%** Regenerative medicine co announces collaboration with Tan Tock Seng Hospital for the development of a novel implant for avascular necrosis (AVN)** AVN is a condition where bone tissue dies due to poor blood supply** About 23.7 mln shares traded, 6.8x the 30-day average** YTD stock down 62.9%, including current session's move  (Reporting by Ananya Verma in Bengaluru)((ananya.verma@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2566656732","isCrawlerRequest":true}